Related Experiment Video

Updated: May 21, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Incidence of neonatal hypoglycemia in babies identified as at risk

Deborah L Harris1, Philip J Weston, Jane E Harding

  • 1Newborn Intensive Care Unit, Waikato District Health Board, Hamilton, New Zealand.

The Journal of Pediatrics
|June 26, 2012
PubMed

Insights

Neonatal hypoglycemia is common in at-risk infants undergoing routine screening. While incidence is similar across risk groups, multiple factors increase hypoglycemia severity, warranting further study on long-term outcomes.

Area of Science:

  • Neonatal Medicine
  • Pediatrics
  • Endocrinology

Background:

  • Routine blood glucose screening is recommended for high-risk newborns.
  • The precise incidence of hypoglycemia in screened infants is not well-established.

Purpose of the Study:

  • To determine the incidence of hypoglycemia in at-risk newborns.
  • To compare hypoglycemia incidence across different at-risk infant categories.

Main Methods:

  • A cohort of 514 infants (≥35 weeks gestation) identified as high-risk were studied.
  • Blood glucose levels were measured using a glucose oxidase method within 48 hours of birth.
  • Infants were categorized by risk factors including size, diabetic mother, and gestational age.

Main Results:

  • Over half of the infants (51%) experienced hypoglycemia (<2.6 mM), with 19% having severe hypoglycemia (≤2.0 mM).
  • Most hypoglycemic episodes (81%) occurred within the first 24 hours, with a mean duration of 1.4 hours.
  • Infants with three or more risk factors showed a higher likelihood of severe hypoglycemia.

Conclusions:

  • Hypoglycemia is prevalent in newborns targeted for routine screening.
  • Current screening protocols do not need to differ based on specific at-risk groups.
  • Multiple risk factors may elevate the severity of neonatal hypoglycemia, but long-term outcomes require further investigation.
Abstract

More Related Videos

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...